(Q37145401)

18 August 2017

1 reference

title

Over-suppression of bone turnover: does it exist? (English)

1 reference

18 August 2017

Juliet Compston

1

1 reference

18 August 2017

publication date

1 December 2007

1 reference

Current osteoporosis reports

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

179-185

1 reference

https://scigraph.springernature.com/pub.10.1007/s11914-007-0014-0

18 August 2017

exact match

0 references

cites work

Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11914-007-0014-0

Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study

21 January 2018

1 reference

12 December 2020

Molecular markers of bone turnover: biochemical, technical and analytical aspects.

1 reference

12 December 2020

Bone remodeling rate and remodeling balance are not co-regulated in adulthood: implications for the use of activation frequency as an index of remodeling rate

1 reference

12 December 2020

Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

Influence of nonenzymatic glycation on biomechanical properties of cortical bone

1 reference

12 December 2020

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

1 reference

12 December 2020

1 reference

12 December 2020

Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women

1 reference

12 December 2020

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

12 December 2020

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1 reference

12 December 2020

Combined inter-observer and inter-method variation in bone histomorphometry

1 reference

12 December 2020

Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels

1 reference

12 December 2020

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial

1 reference

12 December 2020

Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density

1 reference

12 December 2020

Spectroscopic characterization of collagen cross-links in bone

1 reference

12 December 2020

The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover

1 reference

12 December 2020

The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone

1 reference

12 December 2020

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

12 December 2020

Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis

1 reference

12 December 2020

Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma

1 reference

12 December 2020

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

1 reference

12 December 2020

Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy

1 reference

12 December 2020

Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography

1 reference

12 December 2020

Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography

1 reference

12 December 2020

Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate

1 reference

12 December 2020

Seven years of treatment with risedronate in women with postmenopausal osteoporosis

1 reference

12 December 2020

Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women

1 reference

12 December 2020

Histomorphometric assessment of trabecular bone remodelling in osteoporosis

1 reference

12 December 2020

Tetracycline-based histological analysis of bone remodeling

1 reference

12 December 2020

Denosumab in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Severely suppressed bone turnover: a potential complication of alendronate therapy

1 reference

12 December 2020

Targeted and nontargeted remodeling

1 reference

12 December 2020

Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women

1 reference

12 December 2020

Osteopenia, hematopoiesis, and bone remodelling in iliac crest and femoral biopsies: a prospective study of 102 cases of femoral neck fractures

1 reference

12 December 2020

A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women

1 reference

12 December 2020

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

12 December 2020

Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies

1 reference

12 December 2020

Bone fragility and collagen cross-links.

1 reference

12 December 2020

Effects of hormone replacement therapy on cancellous bone microstructure in postmenopausal women.

1 reference

12 December 2020

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

12 December 2020

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience

1 reference

12 December 2020

10.1007/S11914-007-0014-0

Identifiers

DOI

1 reference

18 August 2017

1 reference